Related Experiment Videos
Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia
M G De Simoni1, C Storini, M Barba
1Mario Negri Institute for Pharmacological Research, Milan, Italy. desimoni@marionegri.it
Summary
The C1 inhibitor (C1-INH) significantly reduced brain damage and improved neurological function in a mouse model of focal ischemia. This suggests C1-INH has potent neuroprotective effects against ischemia-reperfusion injury.
Area of Science:
- Neuroscience
- Immunology
- Vascular Biology
Background:
- Complement C1 inhibitor (C1-INH) is the sole known inhibitor of complement C1.
- Ischemia-reperfusion injury is a significant cause of brain damage.
Purpose of the Study:
- To investigate the neuroprotective effects of C1-INH in a murine model of transient focal cerebral ischemia.
- To evaluate the impact of C1-INH on neurological deficits, infarct volume, and cellular responses post-ischemia.
Main Methods:
- Transient focal cerebral ischemia was induced in mice via middle cerebral artery occlusion.
- C1-INH was administered intravenously, and its effects were assessed on neurological deficits, infarct volume, and astrocytic response.
- Neutral red staining was used to identify ischemic brain areas.
Main Results:
- C1-INH treatment significantly improved general (36%) and focal (54%) neurological deficits.
- C1-INH markedly reduced infarct volume (6.69% vs. 24.24% in saline-treated controls).
- Protective effects of C1-INH were observed in the cortex, hippocampus, and striatum, with no significant impact on astrocyte activation.
Conclusions:
- C1-INH demonstrates potent neuroprotective activity in focal ischemia.
- C1-INH effectively mitigates ischemia-reperfusion injury, offering a potential therapeutic strategy.